首页>
外国专利>
AN IN-VITRO METHOD OF PREDICTING THE RESPONSE OF A NON SMALL CELL LUNG CANCER PATIENT TO ERLOTINIB BY DETERMINING PTP4A1 GENE EXPRESSION LEVEL
AN IN-VITRO METHOD OF PREDICTING THE RESPONSE OF A NON SMALL CELL LUNG CANCER PATIENT TO ERLOTINIB BY DETERMINING PTP4A1 GENE EXPRESSION LEVEL
展开▼
机译：通过确定PTP4A1基因表达水平来预测非小细胞肺癌患者对厄洛替尼的反应的体外方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a biomarkei" which is predictive for the clinical benefit of EGFR inhibitor treatment in cancer palienls.
展开▼
